hereditary angioedema
CSL accuses ex-exec, now at Pharming, of stealing trade secrets
Phil Taylor
CSL Behring, hereditary angioedema, Pharming
0 Comment
HAE patients get new option as NICE backs Takeda’s Takhzyro
Richard Staines
hereditary angioedema, NICE, Rare diseases, Takeda
0 Comment
FDA rejects Pharming’s Ruconest HAE label expansion
Joy Persaud
hereditary angioedema, Pharming, Rare diseases, Shire
0 Comment
Shire eyes blockbuster sales as FDA approves HAE therapy
Richard Staines
hereditary angioedema, M&A, Rare diseases, Shire
0 Comment
Shire plans filing for HAE drug after phase 3 success
Richard Staines
hereditary angioedema, orphan, Rare diseases, Shire, Valeant
0 Comment
Lanadelumab could revolutionise treatment of swelling disease.